Amifostine for nasoduodenal delivery (Xerient Pharma)

N/A

Report date: 2026/02/12 20:00:14

Base Information

Drug NameAmifostine for nasoduodenal delivery (Xerient Pharma)
Drug Alias NameXER-001
ClassificationSmall molecules
Mechanisms of ActionAlkaline phosphatase modulators
TargetsAlkaline phosphatase
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesXerient Pharma
China Registration ClassN/A

Develop Information

Active CompaniesXerient Pharma
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A